Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion.

Hogg, Hd Jeffry

Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion. [electronic resource] - European journal of ophthalmology Mar 2021 - 548-555 p. digital

Publication Type: Comparative Study; Journal Article

1724-6016

10.1177/1120672120904669 doi


Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Female
Humans
Intravitreal Injections
Macular Edema--drug therapy
Male
Middle Aged
Ranibizumab--therapeutic use
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Retinal Vein Occlusion--complications
Retrospective Studies
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Visual Acuity--physiology